1.

lebih diperdalam bagian vaksinasi dan mekanisme immunopatogenesis

Jurnal yang bisa digunakan

a. Lukman dkk. A Review of Hantavirus Research in Indonesia: Prevalence in Humans and

Rodents, and the Discovery of Serang Virus, 2019.
b. Khaiboullina et al, Hantaviruses: Molecular Biology, Evolution and Pathogenesis, 2005
c. Schmaljohn, 2012. Vaccines for hantaviruses: progress and issues
d. Terajima M, Ennis FA. T cells and pathogenesis of hantavirus cardiopulmonary syndrome and
hemorrhagic fever with renal syndrome. Viruses. 2011 Jul;3(7):1059-73. doi:
10.3390/v3071059. Epub 2011 Jul 6. PMID: 21994770; PMCID: PMC3185782.
e. Krüger DH, Schönrich G, Klempa B. Human pathogenic hantaviruses and prevention of infection. Hum
Vaccin. 2011 Jun;7(6):685-93. doi: 10.4161/hv.7.6.15197. Epub 2011 Jun 1. PMID: 21508676; PMCID:
PMC3219076.

f. Hjelle, B. (2002). Vaccines against hantaviruses. Expert Review of Vaccines, 1(3), 373–384.
doi:10.1586/14760584.1.3.373 

g. Maes P et al., 2009 Recent approaches in hantavirus vaccine development

h. Mittler 2019 Hantavirus entry: Perspectives and recent advances.

i. Brocato RL, Hooper JW. Progress on the Prevention and Treatment of Hantavirus Disease.
Viruses. 2019 Jul 4;11(7):610. doi: 10.3390/v11070610. PMID: 31277410; PMCID: PMC6669544.